News and Announcements
MedAdvisor Signs Strategic Agreement with Arrow Pharmaceuticals
- Published June 01, 2016 2:46PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
1st June 2016, ASX Announcement
Highlights:
- MedAdvisor has sign a strategic agreement with Arrow Pharmaceuticals, one of Australia’s largest generic pharmaceutical manufacturers
- Arrows Pharmaceuticals’ 35 plus strong national sales teams to promote the MedAdvisor platform to its extensive first-line customer base of over 1,100 pharmacies from June 2016
- Strong platform validation with MedAdvisor now partnered with Australia’s two largest generic companies: Apotex and Arrow Pharmaceuticals
- Aligns with MedAdvisor’s strategy to substantially increase its referrer and patient customer base to drive revenue and growth
MedAdvisor Limied (ASX:MDR, the Company), Australia’s leading digital medication adherence company, is pleased to announce that it has signed a binding strategic agreement with Arrow Pharmaceuticals, Australia’s second largetst generic pharmaceutical manufactures, following the announcement of its Memorandum of Understanding in March 2016.
To view the full announcement, please click on the button below.
Company Updates
BlackRock has named the next Economy. What this latest paper means for Private Market Investors.
BlackRock has put a name on something the smart money has been circling for two years. Its digital assets research team calls it the machine-native economy. The thesis fits in one line. AI is machine-native intelligence. Digital assets are machine-native money. Both are built on the same architecture, and they are converging into a single […]
Where’s the beef? Blackstone just answered the AI question.
In 1984, a fast food ad asked a question that became a catchphrase. Where’s the beef? Jon Gray, President of Blackstone, used that line this month in front of global LPs. It is the question every capital allocator is asking about AI. Trillions of dollars are going into chips, data centres and power. That is […]
The Best of Both Worlds: How Omnique Fund is Rewiring Real World Assets via Tokenisation
For decades, the playbook for Australia’s wholesale investors has remained relatively unchanged: pick between the slow-moving, illiquid reliability of tangible assets like property and gold, or chase the frictionless, high-velocity liquidity of public equity and digital markets. But as macroeconomic volatility spikes and a structural housing deficit reshapes private debt demand, sophisticated investors are demanding […]
Backed By Leading Investment Groups and Family Offices
